Moral injury is not the same wound as PTSD
For most of the last forty years, the language available to describe what happens to a person after combat, after a mass-casualty shift in an ICU, after a bad call on a fire ground, has been the language of post-traumatic stress disorder. PTSD is a fear-based diagnosis. The intrusive memories, the hypervigilance, the startle response, the avoidance—these are the nervous system's attempts to keep a person safe from a threat the brain has not finished processing.
Moral injury is a different wound. It is what happens when a person perpetrates, witnesses, or fails to prevent an act that violates a deeply held moral belief, and the residue is not fear. It is guilt. It is shame. It is the quiet, corrosive sense that one's place in a moral universe has been altered, and that the self that did the act, or failed to stop it, is not the self one believed oneself to be. The two wounds can co-occur in the same person, and often do, but the symptom profiles, the inner architecture, and the treatments that help are not the same.
This distinction matters because the standard PTSD playbook—exposure therapy, prolonged exposure, EMDR, and SSRIs—was built around fear extinction. It addresses the threat memory. It does not, on its own, address the moral injury sitting underneath, and a clinician who confuses the two will treat the wrong wound.
Litz 2009 and the framework that named it
The construct of moral injury entered the clinical literature in a foundational paper by Brett Litz and colleagues, published in Clinical Psychology Review in 2009 (volume 29, pages 695 to 706). Litz et al. defined moral injury as the lasting psychological, biological, spiritual, behavioral, and social impact of perpetrating, failing to prevent, bearing witness to, or learning about acts that transgress deeply held moral beliefs and expectations.
The paper distinguished moral injury from PTSD on several axes. Where PTSD's central affect is fear, moral injury's central affects are guilt and shame. Where PTSD's intrusions are threat-based memories, moral injury's intrusions are self-evaluative—the replaying of one's own action or inaction. Where PTSD calls for fear extinction, moral injury calls for what Litz and colleagues described as moral repair: a process closer to the territory of grief, confession, and meaning reconstruction than to a treatment protocol.
A subsequent body of work, summarized in a 2019 special issue of the Journal of Traumatic Stress on moral injury, has reviewed the conceptual evolution of the construct and reported that clinically significant moral injury affects an estimated 10 to 25 percent of combat-exposed service members, with comparable concern emerging in civilian high-stakes occupations. That review also catalogued early treatment approaches, including Adaptive Disclosure, acceptance-based therapies, and pastoral or chaplain-integrated care.
Who carries moral injury
The construct began with combat veterans, and it remains most heavily studied in that population. Combat veterans are over-represented for obvious reasons: the structural conditions of war include impossible decisions, witnessed atrocity, and split-second actions whose moral weight is felt for decades. The veterans page at our clinic is one of the places this conversation often begins.
But moral injury is not a uniformed condition. The years of the COVID pandemic surfaced a parallel cohort in healthcare workers: ICU nurses and respiratory therapists who allocated ventilators they did not have enough of, hospice teams who withheld families from dying patients because of infection-control rules, emergency-department physicians who triaged in conditions that violated everything their training had told them was right. Many describe the residue in moral-injury language even when they do not yet know the term.
The same construct extends to first responders who arrived too late, to child-protective social workers who returned a child to a home and learned later what happened, to clergy who counseled a parishioner who later took their life, to refugee-resettlement caseworkers whose clients were deported. The unifying feature is not the uniform. It is the structural position: a person placed in a role that required a moral choice they could not make cleanly, with a wound that does not look like fear.
Why pure pharmacology cannot resolve shame
Here is where we have to be plain. There is no medication, ketamine included, that dissolves a moral wound. Shame is not a neurotransmitter imbalance. Guilt is not a receptor problem. The repair of moral injury, when it happens, happens in relationship—with a therapist, with a chaplain or spiritual director, with a peer who has carried something similar, with the slow and sometimes unfinished work of confession, accountability, and meaning reconstruction. That work is mostly therapy, and we want to say so before we say anything else.
Ketamine is FDA-approved as an anesthetic; its use for moral injury, depression, and trauma-spectrum conditions is off-label. Where ketamine has a defensible role in this picture is not as a treatment for the moral injury itself, but as a treatment for what frequently lands on top of moral injury and makes the underlying work impossible. When guilt and shame go untreated for long enough, depression piles on. Anhedonia—the loss of pleasure, motivation, and felt connection—sets in. Sleep collapses. The person becomes too immobilized to sit in a therapist's office and do the slow repair.
What ketamine pharmacology actually does
Ketamine is an NMDA-receptor antagonist. By blocking those receptors, it triggers a downstream surge of glutamate signaling and, over the following hours to days, the formation of new synaptic connections in regions of the brain associated with mood regulation, stress response, and cognitive flexibility. This is the neuroplastic window that has made ketamine clinically interesting for treatment-resistant depression and, by extension, for trauma-spectrum conditions where depression is a major overlay.
The most relevant adjacent evidence base for moral injury is the PTSD literature. A 2021 randomized controlled trial by Feder and colleagues, published in American Journal of Psychiatry, evaluated six intravenous ketamine infusions in 30 patients with chronic PTSD and reported significant reductions on the Clinician-Administered PTSD Scale for DSM-5 at the two-week mark. That trial was not designed to study moral injury specifically, and its outcomes were measured against PTSD criteria, not Litz's framework. But for the substantial group of patients who carry both wounds, it is the closest thing we have to direct evidence, and it suggests that the trauma-spectrum overlay is responsive even when the underlying moral injury remains.
For the depression-collapsed-into-anhedonia presentation that frequently shadows moral injury, the broader treatment-resistant depression evidence base also applies. Nothing in that literature suggests ketamine resolves the moral injury itself. It does suggest, in the population for whom standard antidepressants have failed, that the depression layer can lift.
Where ketamine might help, and where it will not
The honest framing we use in consultation goes something like this. If you are carrying moral injury and the depression that has settled on top of it has rendered you unable to engage in therapy, unable to feel anything resembling connection, unable to imagine a future, then ketamine may have a role—adjunctive to therapy, not in place of it—in lifting that overlay enough that the harder work becomes possible again.
If you are carrying moral injury and what you need is a place to tell the story, to be heard without flinching, to begin the long arc of moral repair, ketamine is not your treatment. Find a therapist trained in Adaptive Disclosure or Acceptance and Commitment Therapy. Find a chaplain or spiritual-care provider you trust. Find a peer-led group—Vets4Warriors, Frontline Wellness, organizations specific to your profession—where the room understands the wound without explanation.
And if you are carrying both moral injury and complex PTSD, or moral injury alongside unresolved grief, the picture is layered and the sequencing of care matters. Those are conversations that benefit from a coordinated team rather than a single provider.
How we coordinate with therapists, chaplains, and peer support
At Music City Ketamine, we treat ketamine therapy as one piece of a larger care plan, not the plan itself. For patients with moral injury or trauma-spectrum presentations, we ask early about the therapist or pastoral-care relationship. If you do not have one, we will encourage you to establish one before or alongside infusion treatment. The infusion is the easier part of this work. The integration—making sense of what surfaced, sitting with shame without acting on it, doing the repair—happens in therapy.
Marla Peterson, CRNA, oversees every infusion with anesthesia-level monitoring throughout: continuous pulse oximetry, blood pressure, and heart-rate tracking. The clinical environment is intentionally quiet and private. We do not ask you to disclose the precipitating event to us. The conversation here focuses on current symptoms, depression severity, sleep, safety, and goals. Disclosure work belongs in your therapy relationship, on your timeline.
Cost is a real consideration in long-arc work. Ketamine infusions at our clinic are $475 per session, and insurance typically does not cover off-label use. We are direct about that from the first conversation so the financial picture is part of the decision rather than a surprise.
Honest expectations
- Ketamine does not dissolve moral wounds. Research suggests it can reduce depression and trauma symptoms in adjacent populations, but no study has shown it resolves the guilt-and-shame core of moral injury itself.
- Therapy is the work. Adaptive Disclosure, Acceptance and Commitment Therapy, structured pastoral care, and peer-led groups remain the modalities most associated with moral repair in the published literature.
- Not everyone responds. Even in the depression and PTSD populations where ketamine has the strongest evidence, a meaningful minority of patients do not benefit. We will not predict that you will.
- This is slow work. Moral injury did not arrive in a single session, and it does not leave in one either. Expect a treatment arc measured in months and years, with infusions used adjunctively if at all.
- Talk to your prescribing provider. Do not start, stop, or change any medication on your own. Decisions about your existing treatment plan belong with the clinician who prescribed it.
We want to be useful where we can be useful, and clear about where we cannot. If the depression has collapsed onto everything else, we may be able to help lift that. The repair underneath is yours, and it belongs to the people you trust to walk it with you.